lactic acid has been researched along with huperzine a in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (83.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, X; Gao, Y; Ping, Q | 2 |
| Chu, DF; Li, YX; Liu, K; Liu, WH; Song, JL | 1 |
| Fu, XD; Gao, YL; Ping, QN; Ren, T | 1 |
| Chen, D; Ding, P; Gao, P; Wei, J; Xu, H; Yuan, Z | 1 |
| Chu, DF; Fu, XQ; Li, YX; Liu, K; Liu, WH | 1 |
| Chen, D; Ding, P; Gao, P; Gao, Q; Sun, J; Xu, H | 1 |
| Fu, XD; Gao, YL; Ping, QN | 1 |
| Fu, F; Liu, J; Liu, K; Ma, H; Wang, C; Zhang, T | 1 |
| Chu, D; Li, Y; Li, Z; Liu, W; Tian, J | 1 |
| Fu, F; He, J; Li, Y; Liu, W; Sun, K; Tian, J; Ye, L; Yu, P; Yu, X | 1 |
| Hua, H; Jiang, Y; Meng, Q; Mu, H; Sun, K; Wang, A; Wang, Y; Wu, Z | 1 |
12 other study(ies) available for lactic acid and huperzine a
| Article | Year |
|---|---|
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Topics: Alkaloids; Biocompatible Materials; Cholinesterase Inhibitors; Drug Compounding; Hot Temperature; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes; Solvents | 2005 |
Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Desiccation; Dogs; Drug Compounding; Drug Stability; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes; Solubility; Water | 2005 |
Preparation and in vivo evaluation of huperzine A-loaded PLGA microspheres.
Topics: Alkaloids; Animals; Cholinesterase Inhibitors; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2005 |
In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Topics: Alkaloids; Animals; Drug Compounding; Injections, Subcutaneous; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Neuroprotective Agents; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Sesquiterpenes; Viscosity | 2006 |
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Topics: Alkaloids; Alzheimer Disease; Delayed-Action Preparations; Drug Compounding; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2005 |
Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
Topics: Alkaloids; Animals; Area Under Curve; Biological Availability; Cholinesterase Inhibitors; Chromatography, Liquid; Dogs; Drug Compounding; Female; Injections, Intramuscular; Injections, Subcutaneous; Lactic Acid; Male; Mass Spectrometry; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2006 |
Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Calorimetry, Differential Scanning; Cerebral Cortex; Cholinesterase Inhibitors; Delayed-Action Preparations; Drug Stability; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Sesquiterpenes | 2007 |
[Effect of preparation technique on in vitro release mechanism of huperzine A microspheres].
Topics: Alkaloids; Cholinesterase Inhibitors; Drug Compounding; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2006 |
Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine.
Topics: Acetylcholinesterase; Alkaloids; Animals; Avoidance Learning; Cerebral Cortex; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Male; Memory Disorders; Mice; Microspheres; Muscarinic Antagonists; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reaction Time; Scopolamine; Sesquiterpenes; Spectrophotometry | 2007 |
Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice.
Topics: Alkaloids; Animals; Cholinesterase Inhibitors; Lactic Acid; Memory Disorders; Mice; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2007 |
Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
Topics: Acetylcholinesterase; Administration, Oral; Alkaloids; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; GPI-Linked Proteins; Injections, Intramuscular; Lactic Acid; Male; Memory; Microspheres; Particle Size; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Technology, Pharmaceutical | 2013 |
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Topics: Administration, Intranasal; Alkaloids; Alzheimer Disease; Animals; Brain; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Lactoferrin; Mice; Nanoparticles; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sesquiterpenes; Tissue Distribution | 2018 |